Antiviral agents active against influenza A viruses

被引：572

作者：

De Clercq, Erik ^{[1
]}

机构：

[1] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium

来源：

NATURE REVIEWS DRUG DISCOVERY | 2006年 / 5卷 / 12期

关键词：

D O I：

10.1038/nrd2175

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

The recent outbreaks of avian influenza A (H5N1) virus, its expanding geographic distribution and its ability to transfer to humans and cause severe infection have raised serious concerns about the measures available to control an avian or human pandemic of influenza A. In anticipation of such a pandemic, several preventive and therapeutic strategies have been proposed, including the stockpiling of antiviral drugs, in particular the neuraminidase inhibitors oseltamivir (Tamiflu; Roche) and zanamivir (Relenza; GlaxoSmithKline). This article reviews agents that have been shown to have activity against influenza A viruses and discusses their therapeutic potential, and also describes emerging strategies for targeting these viruses.

引用

页码：1015 / 1025

页数：11

共 119 条

[31] Neuraminidase inhibitor-rimantadine combinations exert additive and synergistic anti-influenza virus effects in MDCK cells [J].

Govorkova, EA ;

Fang, HB ;

Tan, M ;

Webster, RG .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (12) :4855-4863

[32] Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors [J].

Gubareva, LV .

VIRUS RESEARCH, 2004, 103 (1-2) :199-203

[33] Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir [J].

Gubareva, LV ;

Kaiser, L ;

Matrosovich, MN ;

Soo-Hoo, Y ;

Hayden, FG .

JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (04) :523-531

[34] Total synthesis of A-315675: A potent inhibitor of influenza neuraminidase [J].

Hanessian, S ;

Bayrakdarian, M ;

Luo, XH .

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2002, 124 (17) :4716-4721

[35]

Hayden F G, 1996, Antivir Ther, V1, P51

[36] COMBINED INTERFERON-ALPHA-2, RIMANTADINE HYDROCHLORIDE, AND RIBAVIRIN INHIBITION OF INFLUENZA-VIRUS REPLICATION INVITRO [J].

HAYDEN, FG ;

SCHLEPUSHKIN, AN ;

PUSHKARSKAYA, NL .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (01) :53-57

[37] Management of influenza in households: A prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis [J].

Hayden, FG ;

Belshe, R ;

Villanueva, C ;

Lanno, R ;

Hughes, C ;

Small, I ;

Dutkowski, R ;

Ward, P ;

Carr, J .

JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (03) :440-449

[38] Influenza viruses resistant to the antiviral drug oseltamivir: Transmission studies in ferrets [J].

Herlocher, ML ;

Truscon, R ;

Elias, S ;

Yen, HL ;

Roberts, NA ;

Ohmit, SE ;

Monto, AS .

JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (09) :1627-1630

[39] Influenza virus carrying an R292K mutation in the neuraminidase gene is an transmitted in ferrets [J].

Herlocher, ML ;

Carr, J ;

Ives, J ;

Elias, S ;

Truscon, R ;

Roberts, N ;

Monto, AS .

ANTIVIRAL RESEARCH, 2002, 54 (02) :99-111

[40] Synthesis and anti-influenza virus activity of 7-O-alkylated derivatives related to zanamivir [J].

Honda, T ;

Masuda, T ;

Yoshida, S ;

Arai, M ;

Kaneko, S ;

Yamashita, M .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (15) :1925-1928

← 1 2 3 4 5 6 7 8 9 10 →